These findings demonstrate that ABHD5 suppresses c-MYC-driven oncogenic activity through a mechanism that is independent of PNPLA2-mediated lipolysis, suggesting a previously unrecognized noncanonical signaling role for ABHD5 in regulating MYC expression and cancer cell growth. The gene discussed is ABHD5; the disease is cancer.